These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239 [TBL] [Abstract][Full Text] [Related]
4. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Latagliata R; Petti MC; Fenu S; Mancini M; Spiriti MA; Breccia M; Brunetti GA; Avvisati G; Lo Coco F; Mandelli F Blood; 2002 Feb; 99(3):822-4. PubMed ID: 11806982 [TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG). Asou N; Adachi K; Tamura J; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Sakamaki H; Tsubaki K; Saito K; Ohno R Cancer Chemother Pharmacol; 1997; 40 Suppl():S30-5. PubMed ID: 9272131 [TBL] [Abstract][Full Text] [Related]
6. Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features. Au WY; Lam CC; Ma ES; Man C; Wan T; Kwong YL Hum Pathol; 2001 Jan; 32(1):126-9. PubMed ID: 11172306 [TBL] [Abstract][Full Text] [Related]
7. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond. Tallman MS Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894 [TBL] [Abstract][Full Text] [Related]
8. The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy. Ciftciler R; Haznedaroglu IC; Ozcebe O; Aksu S; Sayınalp N; Goker H; Demiroglu H; Buyukasık Y Immunopharmacol Immunotoxicol; 2020 Feb; 42(1):17-21. PubMed ID: 31744339 [No Abstract] [Full Text] [Related]
9. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. Kanamaru A; Takemoto Y; Tanimoto M; Murakami H; Asou N; Kobayashi T; Kuriyama K; Ohmoto E; Sakamaki H; Tsubaki K Blood; 1995 Mar; 85(5):1202-6. PubMed ID: 7858250 [TBL] [Abstract][Full Text] [Related]
10. Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature. Gaut D; Sasine J; Schiller G Leuk Res Rep; 2018; 9():65-71. PubMed ID: 29892552 [TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia presenting as a paraspinal mass. Shah NN; Stonecypher M; Gopal P; Luger S; Bagg A; Perl A J Community Support Oncol; 2016 Mar; 14(3):126-9. PubMed ID: 27058871 [TBL] [Abstract][Full Text] [Related]
12. Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia. Ojeda-Uribe M; Schneider A; Luquet I; Berceanu A; Cornillet-Lefebvre P; Jeandidier E; Lioure B; Ades L; Mauvieux L; Himberlin C Eur J Haematol; 2012 Sep; 89(3):267-72. PubMed ID: 22591288 [TBL] [Abstract][Full Text] [Related]
13. Acute promyelocytic leukemia. New methods in diagnosis and treatment. Varghese L; Janckila A; Yam LT J Ky Med Assoc; 1999 Feb; 97(2):61-5. PubMed ID: 10073058 [TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript. Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486 [TBL] [Abstract][Full Text] [Related]
15. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia. Batzios C; Hayes LA; He SZ; Quach H; McQuilten ZK; Wall M; Campbell LJ Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661 [TBL] [Abstract][Full Text] [Related]
16. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis]. Xu SN; Chen JP; Liu JP; Xia Y Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733 [TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments. Özpolat B Turk J Haematol; 2009 Jun; 26(2):47-61. PubMed ID: 27265273 [TBL] [Abstract][Full Text] [Related]
18. Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases. Vanegas YAM; Azzouqa AM; Menke DM; Foran JM; Vishnu P Hematol Rep; 2018 Sep; 10(3):7658. PubMed ID: 30283621 [TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan. Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028 [TBL] [Abstract][Full Text] [Related]